Using Anti-CD38 Monoclonal Antibodies as Treatment in Multiple Myeloma

This roundtable series explores triplet and quadruplet combination therapies, including anti-CD38 monoclonal antibodies, with or without transplant in patients with multiple myeloma as discussed by participants at virtual live events.